Unregistered Sales of Equity Securities

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp as indicated in metadata) on September 13, 2017. The registrant is an emerging growth company incorporated in Nevada. The report details an amendment to an information agent agreement with Katalyst Securities LLC.

Key Financial Metrics

The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to a specific transaction:

  • Compensation Value: $200,000 (cash compensation replaced by warrants).
  • Warrant Quantity: 200,000 shares of common stock.
  • Exercise Price: $1.50 per share.
  • Par Value: $0.001 per share.

Material Changes

The material change reported is the issuance of unregistered equity securities. On September 13, 2017, the Company amended its agreement with Katalyst Securities LLC. Instead of paying $200,000 in cash for services rendered as an information agent for a recently completed rights offering, the Company issued 200,000 warrants. These warrants are exercisable immediately and expire three years from issuance.

Guidance, Outlook, and Risks

The filing contains no management guidance, outlook, or discussion of general business risks. The transaction was executed in reliance upon the exemption from registration under Section 4(a)(2) of the Securities Act. The document references a form of warrant attached as Exhibit 4.1 for complete terms.

Investor Verification Checklist

  • Verify the exact terms and conditions of the 200,000 warrants issued to Katalyst Securities LLC by reviewing Exhibit 4.1.
  • Confirm the status and completion of the "recently completed rights offering" mentioned as the context for these services.
  • Assess the potential dilution impact of 200,000 shares exercisable at $1.50 per share on the current share count.
  • Note the discrepancy between the metadata company name (Chronoscale Holdings Corp) and the actual registrant (Ekso Bionics Holdings, Inc.).
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.